Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer
![](/xmlui/themes/Mirage2//images/mime.png)
Erişim
info:eu-repo/semantics/closedAccessTarih
2014Yazar
Bilici, AhmetSelçukbiricik, Fatih
Demir, Nazan
Öven Ustaalioğlu, Bala Başak
Dikillitaş, Mustafa
Yıldız, Özcan
Üst veri
Tüm öğe kaydını gösterKünye
Bilici, A., Selçukbiricik, F., Demir, N., Öven Ustaalioğlu, B. B., Dikillitaş, M. ve Yıldız, Ö. (2014). Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer. 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Chicago, IL: American Society of Clinical Oncology.Özet
…
WoS Q Kategorisi
Q1Kaynak
50th Annual Meeting of the American-Society-of-Clinical-OncologyCilt
32Sayı
15Koleksiyonlar
- Bildiri Koleksiyonu [516]
- WoS İndeksli Yayınlar Koleksiyonu [6677]